Search results
Results from the Health.Zone Content Network
Cardinal now expects 2024 adjusted earnings in the range of $7.30 to $7.40 per share, compared with $7.20 to $7.35 per share forecast previously. According to LSEG data, analysts were expecting an ...
The Optum contracts, signed in 2015, contributed 16% of Cardinal's total revenue in fiscal year 2023, but the bulk of the shipments mainly comprised non-specialty medicines, Cardinal Health said.
Cardinal Health, Inc. Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. [4]
The regulator's warning comes after Cardinal Health initiated a recall for its Monoject syringes due to incompatibility concerns with syringe pumps. Monoject syringes are used to inject into or ...
Kevin Joseph Farrell KGCHS (born September 2, 1947) is an Irish-born prelate of the Catholic Church who has been a cardinal and has served as prefect of the Dicastery for the Laity, Family and Life since 2016. In 2019, he was appointed Camerlengo of the Holy Roman Church as well. After his ordination in 1978, Farrell served as a chaplain and ...
Cardinal Technologies was founded in February 1987 by Harold Krall and seven other ex-employees of the RCA Corporation 's New Products Division research and development office and factory in Lancaster, Pennsylvania. [2] [1] In 1986, General Electric completed their acquisition of the ailing RCA Corporation, divesting RCA's New Products Division ...
AOL latest headlines, entertainment, sports, articles for business, health and world news.
CareFusion was created in 2009 as a spinoff of medical technology businesses from Cardinal Health. [1] It began publicly trading on the New York Stock Exchange on September 1, 2009. [2] Cardinal's core business was drug distribution, a low-margin and low-risk, predictable business, with which the higher-margin, higher-risk medical technology ...